ViiV Healthcare
Headquarters country
United Kingdom
Registry sponsor category
Industry
- Other names
- ViiV Healthcare
- Company name
- ViiV Healthcare
- Organisation type
- Industry
- Registered legal name
- VIIV HEALTHCARE LIMITED
- Registry sponsor category
- Industry
- Website
- https://viivhealthcare.com/
- Legal Entity Identifier (LEI)
- 213800PCGWGORUQKMI06
- Wikidata ID
- Q7929051
Related records
Parent companies (1)
- GlaxoSmithKline Direct and ultimate parent
Trials (395)
- 'COMBINE-2': Real-world Evidence for Effectiveness of Two Drug Regimen, Antiretroviral Therapy With Integrase Inhibitors Plus a Reverse Transcriptase Inhibitor
- #AWARE.HIV Europe: Supporting Healthcare Professionals to Find Undiagnosed HIV in European Hospitals: An Effectiveness-implementation Trial.
- 2000 HIV Human Functional Genomics Partnership Program
- 2DR Versus 3DR in a Prospective Randomized Controlled Switch Trial
- 48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection
- A Clinical Study Of An Investigational Regimen Including Marketed HIV Drugs In HIV-1 Pediatric Subjects Ages 2-18 Years
- A Clinical Trial of GSK3640254 + Dolutegravir (DTG) in Human Immunodeficiency Virus-1 Infected Treatment-naive Adults
- A Compassionate Access Protocol For Those Patients Who Have Completed A4001029
- A Continued Access Study for Participants Transitioning From ViiV Healthcare-sponsored or ViiV Healthcare-collaborative Parent Studies for HIV Treatment
- A Dose Ranging Study Of GW640385 Boosted With Ritonavir (Rtv) In Comparison To A RTV-Boosted Protease Inhibitor (PI) In HIV-1 Infected PI-Experienced Adults
- A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects
- A Dose-Range Finding Clinical Trial Study in Human Immunodeficiency Virus (HIV-1) Infected Treatment-Naive Adults
- A Drug Interaction Study Evaluating GSK2248761 and Raltegravir Pharmacokinetics in Healthy Adult Subjects
- A Drug Interaction Study Evaluating Plasma GSK2248761 and GSK1349572 Pharmacokinetics in Healthy Adult Subjects.
- A Drug-drug Interaction Study Between BMS-663068 and Oral Contraceptives in Healthy Female Volunteers (DDI)
- A Food-effect Study of the Pediatric Dispersible Tablet Formulations of TRIUMEQ® and DOVATO® in Healthy Adult Participants
- A HIV Study Of A Fixed-Dose Combination Tablet In Antiretroviral Experienced Patients
- A Long Term Safety Study Of Lersivirine For The Treatment Of HIV-1 Infection In Subjects Who Have Completed Treatment With Lersivirine In Studies A5271015 And A5271022
- A Open-label, Drug-Drug Interaction With Maraviroc (DDI)
- A Phase 1 Antiretroviral Drug-Drug Interaction Study in Healthy Volunteers (DDI)